Resource Center
Browse industry research articles, publications, and other important resources.
-
browse
By Topic
By Disease Area
-
Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project
Posted May 21, 2018 by Elizabeth Clearfield, MHS ,Donna Messner, PhD ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Iorio A, Skinner MW, Clearfield E, Messner D, Pierce GF, Witkop M, Tunis S; for the coreHEM panel. Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project. Haemophilia. 2018;00:1–6. https://doi.org/10.1111/hae.13504
-
coreHEM: Developing Comparative Effectiveness Outcomes for Gene Therapy in Hemophilia
Posted May 21, 2018 by Elizabeth Clearfield, MHS ,Donna Messner, PhD ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
coreHEM has produced the first set of guidelines recommending a specific, minimum set of outcomes to include in hemophilia gene therapy clinical trials. This core set will ensure that patient perspectives on critical outcomes are included in pivotal trials, allow fair comparisons between alternative treatments, and allow more accurate assessments of the value of these therapies. The coreHEM project was jointly led by the Green Park Collaborative (GPC), the National Hemophilia Foundation (NHF), and McMaster University.
-
Insurance Coverage for Genomic Tests
Posted April 20, 2018 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Phillips KA, Trosman JR, Deverka PA, Quinn B, Tunis S, Neumann PJ, Chambers JD, Garrison LP Jr, Douglas MP, Weldon CB. Insurance coverage for genomic tests. Science 2018 April 20. 360(6386):278-279. doi: 10.1126/science.aas9268. Epub 2018 Apr 19. PMID: 29674586
-
Choosing Important Health Outcomes for Comparative Effectiveness Research: An updated systematic review and involvement of low and middle income countries.
Posted February 13, 2018 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Davis K, Gorst SL, Harman N, Smith V, Gargon E, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR. Choosing important health outcomes for comparative effectiveness research: an updated systematic review and involvement of low and middle-income countries. PONE-D-17-33253R1. PLoS One. 2018 Feb 13;13(2):e0190695. doi: 10.1371/journal.pone.0190695. eCollection 2018. PMID: 29438429 PMCID: PMC5810981 DOI: 10.1371/journal.pone.0190695
-
Stakeholder Perspectives Regarding Alternate Approaches to Informed Consent for CER
Posted December 5, 2017 by Sean Tunis, MD, MSc ,Ellen Tambor, MA ,Rachael Moloney, MHS {categories}in{category_name}, {/categories}
Morain S, Tambor E, Moloney R, Kass N, Tunis S, Hallez K, Faden R. Stakeholder perspectives regarding alternative approaches to informed consent for comparative effectiveness research. Learn Health Sys 2017;e10047. doi: 10.1002/lrh2.10047
-
Core Outcome Set-STAndards for Development: The COS-STAD recommendations
Posted November 16, 2017 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR. Core Outcome Set-STAndards for Development: The COS-STAD recommendations. PLoS Med 2017;14(11):e1002447. doi: 10.1371/journal.pmed.1002447. eCollection. PMID: 29145404
-
Best Practices for the Design, Implementation, Analysis, and Reporting of Oncology Trials with High Rates of Treatment Switching
Posted October 7, 2016 by Rob Conley, MD, JD, MPH ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
GPC released a report that provides guidance for researchers who lead oncology drug trials that may involve substantial treatment switching. Treatment switching most often occurs when a patient moves from the control to the experimental group during a clinical trial – for example, because the patient’s disease has progressed and they want to try the experimental treatment.
-
Medical and pharmacy coverage decision making at the population level (2014)
Posted June 14, 2015 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Mohr PE, Tunis SR. Medical and pharmacy coverage decision making at the population level. J. Manag Care Pharm. 2014;20(6):547-554. PMID: 24856592
-
The views of quality improvement professionals and comparative effectiveness researchers on ethics, IRBs, and oversight (2015)
Posted April 10, 2015 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Whicher D, Kass N, Saghai Y, Faden R, Tunis S, Pronovost P. The views of quality improvement professionals and comparative effectiveness researchers on ethics, IRBs, and oversight. J Empir Res Hum Res Ethics. 2015;10(2):132-44. doi:10.1177/1556264615571558
-
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients (2015)
Posted February 4, 2015 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Eichler H-G, Baird LG, Barker R, … Tunis SR, et al. From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. Clin Pharmacol Ther. 2015;97(3):234-46. doi:10.1002/cpt.59. PMID: 25669457
-
Reimbursing NGS Testing. Clinical OMICs – Molecular diagnostics in personalized medicine (2015)
Posted January 15, 2015 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis S. Reimbursing NGS Testing. Clinical OMICs – Molecular diagnostics in personalized medicine. online digital publication (http://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss1/#/20). 2015;2(1):21-23.
-
What can comparative effectiveness research contribute to integrative health in international perspective? (2014)
Posted November 6, 2014 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Witt C, Withers SR, Grant S, Lauer M, Tunis SR, Berman B. What can comparative effectiveness research contribute to integrative health in international perspective? J Altern Complement Med. 2014;20(11):874-80. doi: 10.1089/acm.2014.0073. PMID: 25372702. PMCID: PMC4238246
-
A Multi-stakeholder Agenda to Advance Enhanced Recovery for U.S. Surgical Patients
Posted October 9, 2014 by Rachael Moloney, MHS ,Rob Conley, MD, JD, MPH ,Donna Messner, PhD ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
This white paper builds upon earlier work, including a multi-stakeholder forum in which participants discussed potential challenges and opportunities to accelerate the adoption of Enhanced Recovery Protocols (ERPs) in the U.S. The white paper shares key insights from the forum regarding potential steps to overcome barriers, and proposes a roadmap to accelerate the adoption of ERPs in the U.S.
-
Accelerated access to innovative medicines for patients in need (2014)
Posted July 9, 2014 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Baird LG, Banken R, Eichler H-G, Kristensen FB, Lee DK, Lim JCW, Lim R, Longson C, Pezalla E, Salmonson T, Samaha D, Tunis S, Woodcock J, Hirsch G. Accelerated access to innovative medicines for patients in need. Clin Pharmacol Ther. 2014;96(5):559-71. doi: 10.1038/clpt.2014.145. PMID: 25006877
-
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes? (Oct 2013)
Posted October 23, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Calonge N, Klein RD, Berg JS, et al. Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes? Genet Med. 2013; doi: 10.1038/gim.2013.141. PMID: 24071797.
-
Medicare Policy on Bariatric Surgery: Decision Making in the Face of Uncertainty (Sept 2013)
Posted September 12, 2013 by Sean Tunis, MD, MSc ,Donna Messner, PhD {categories}in{category_name}, {/categories}
Tunis SR, Messner DA. Medicare policy on bariatric surgery: decision making in the face of uncertainty. J Amer Med Assoc. 2013: doi:10.1001/jama.2013.278849
-
Recommendations for the Design of Phase 3 Pharmaceutical Trials that are more Informative for Patients, Clinicians, and Payers (Sept 2013)
Posted September 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Sonnad SS, Mullins CD, Whicher D, Goldsak J, Mohr PE, Tunis SR. Contem Clin Trials. 2013:pii:S1157-7144(13):132-138
-
Ethics and Informed Consent for Comparative Effectiveness Research with Prospective Electronic Clinical Data (August 2013)
Posted August 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Faden RR, Kass, NE, Whicher DM, Stewart W, Tunis SR. Med Care. 2013;51(8 Suppl 3):S53-7. doi: 10.1097/MLR.0b013e31829b1e4b. PMID: 23793051
-
Break a Vicious Cycle (July 2013)
Posted July 31, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Hayes DF, Allen J, Compton C, Gustavsen G, Leonard DGB, McCormack R, Newcomer L, Pothier K, Ransohoff D, Schilsky RL, Sigal E, Taube SE, Tunis SR. Sci Transl Med. 2013:5(196):196cm6. doi:10.1126scitranslmed.3005950
-
Encouraging Value-based Insurance Designs in State Health Insurance Exchanges (July 2013)
Posted July 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Buttorff CA, Tunis SR, Weiner JP. Am J Manag Care. 2013;19(7):593-600. PMID: 23919422
-
Establishing Work Priorities for GPC-USA (May 2013)
Posted May 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Penny Mohr, and Sean Tunis, MD, MSc gave this presentation at the Inaugural Green Park Collaborative meeting.
-
An Overview of the Green Park Collaborative (May 2013)
Posted May 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Sean Tunis, MD, MSc, gave this presentation at the inaugural meeting of the Green Park Collaborative
-
Design of Clinical Studies of Pharmacologic Therapies for Alzheimer’s Disease (April 2013)
Posted April 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
This EGD on Alzheimer's disease tests a process for developing disease-specific guidance for clinical studies that meet the needs of both payers and health technology assessment bodies.
-
Recommendations from the EGAPP Working Group: Can Testing of Tumor Tissue for Mutations in EGFR Pathway Downstream Effector Genes in Patients with Metastatic Colorectal Cancer Improve Health Outcomes by Guiding Decisions Regarding anti-EGFR Therapy? (Feb 2013)
Posted February 21, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Calonge N, Fisher NL, Berg AO, et al. Genet Med. 2013; doi: 10.1038/gim.2012.184. PMID: 23429431.
-
Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update (January 2013)
Posted January 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Veenstra DL, Piper M, Tunis SR et al. Genet Med. 2013;15(1):14-24. doi: 10.1038/gim.2012.106. PMID: 22955111
-
An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics (January 2013)
Posted January 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Faden RR, Kass NE, Goodman SN, Pronovost P, Tunis SR, Beauchamp TL. Hastings Center Report. 2013:43(s1):S16-S27. doi: 10.1002/hast.134
-
The Research-treatment Distinction: A Problematic Approach for Determining Which Activities Should have Ethical Oversight (January 2013)
Posted January 1, 2013 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Kass NE, Faden RR, Goodman SN, Pronovost P, Tunis SR, Beauchamp TL. Hastings Center Report. 2013;43(s1):S4-S15. doi: 10.1002/hast.133
-
Stakeholder Participation in Comparative Effectiveness Research: Defining a Framework for Effective Engagement (December 2012)
Posted December 30, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Deverka PA, Lavallee DM, Desai PJ, Esmail LC, Ramsey SD, Veenstra DL, Tunis SR. J Comp Eff Res. 2012;1(2):181–194. PMID: 22707880. PMCID: PMC3371639
-
Incorporating Stakeholder Perspectives in Developing a Translation Table Framework for Comparative Effectiveness Research (December 2012)
Posted December 1, 2012 by Sean Tunis, MD, MSc ,Rachael Moloney, MHS ,Donna Messner, PhD {categories}in{category_name}, {/categories}
Gliklich RE, Tunis SR, Mohr PE, Messner DA, Moloney RM, Karkare SU, et al. J Comp Eff Res. 2012; 1(3), 281-292. doi: 10.2217/cer.12.25.
-
Recommendations for Incorporating Patient-reported Outcomes into Clinical Comparative Effectiveness Research in Adult Oncology (December 2012)
Posted December 1, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Basch E, … Spencer MR, Tunis SR, et al. J Clin Oncol. 2012;30(34);4249-4255. doi: 10.1200/JCO.2012.42.5967. PMID:23071244
-
Improving the Efficiency and Effectiveness of Pragmatic Clinical Trials in Older Adults in the United States.
Posted November 1, 2012 by Sean Tunis, MD, MSc ,Rachael Moloney, MHS {categories}in{category_name}, {/categories}
Saag KG, Mohr PE, Esmail L, Wright N, Curtis JR, Cutter G, Delzell E, Gary LC, Lewis CE, Harrington TM, Karkare SU, Kilgore ML, Moloney R, Mudano AS, Oliveira A, Singh J, Warriner A, Zhang J, Berger M, Cummings SR, Pace W, Solomon DH, Wallace R, Tunis SR. Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States. Contemp Clin Trials. 2012;33(6)1211-1216. doi: 10.1016/j.cct.2012.07.002. PMID: 22796098
-
Proposed Recommendations for Designing Clinical Trials for “New Indications” of Approved Oncology Drugs for Treatment of Late Stage Disease (September 2012)
Posted September 3, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
This EGD provides a framework to guide the design and implementation of prospective clinical trials for FDA-approved oncology drugs used outside their current labeled indications to treat late stage cancer.
-
Improving Comparative Effectiveness Research: New Methodological Standards Focus on Quality and Relevance of Research to Patients (August 2012)
Posted August 1, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR. BMJ. 2012;345:e5160. doi: 10.1136/bmj.e5160.
-
Research on the Treatment of Atrial Fibrillation (July 2012)
Posted July 11, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
This EGD outlines how future studies can improve our knowledge of atrial fibrillation by addressing certain critical aspects of study design. It also provides a set of priorities, which are intended to address our lack of understanding of disease progression, optimal timing of treatments, and/or the history of disease.
-
The Role for Pragmatic Randomized Controlled Trials (pRCTs) in Comparative Effectiveness Research (July 2012)
Posted July 2, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Chalkidou K, Tunis SR, Whicher DM, Fowler R, Zwarenstein M. Clin Trials. 2012;9(4):436-446. doi: 10.1177/1740774512450097. PMID: 22752634
-
Building the Evidence Base for Decision Making in Cancer Genomic Medicine Using Comparative Effectiveness Research (July 2012)
Posted July 1, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Goddard KA, Knaus WA, Tunis SR, et al. Genet Med. 2012;14(7):633-642. doi: 10.1038/gim.2012.16. PMID: 22516979
-
Bending the Cost Curve Through Comparative Effectiveness Research (June 2012)
Posted June 2, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
During a presentation at ASCO 2012, Sean Tunis summarized how CER can help provide better information about the costs and benefits of different treatment options, which when combined with the right incentives, can reduce the cost of healthcare.
-
Incorporating Stakeholder Perspectives In Developing a Translation Table Framework for Comparative Effectiveness Research (May 2012)
Posted May 1, 2012 by Donna Messner, PhD ,Rachael Moloney, MHS ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Gliklich RE, Tunis SR, Mohr PE, Messner DA, Moloney RM, Karkare SU, et al. . J Comp Eff Res. 2012; 1(3), 281-292. doi: 10.2217/cer.12.25.
-
Methodological Guidance for Molecular Diagnostics Research in Oncology Workshop Slides May 2012
Posted May 1, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
A presentation by Sean Tunis on evidentiary standards for determining the clinical utility of genomics-based diagnostic tests.
-
International Collaboration in the Use of Registries for New Devices and Procedures (April 2012)
Posted April 17, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Campbell B, Patrick H; REGISTER GROUP – Tunis SR. Br J Surg. 2012;99(6):744-745. doi: 10.1002/bjs.8791. PMID: 22508386
-
How Well Do Randomized Trials Inform Decision Making: Systematic Review Using Comparative Effectiveness Research Measures on Acupuncture for Back Pain? (Feb 2012)
Posted February 28, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Witt CM, Manheimer E, Tunis SR, et al. PLoS ONE. 2012;7(2):e32399. doi: 10.1371/journal.pone.0032399
-
Using Health Technology Assessment to Identify Gaps in Evidence and Inform Study Design for Comparative Effectiveness Research (January 2012)
Posted January 1, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Turkelson CM. J Clin Oncol. 2012;30(34):4256-4261. doi: 10.1200/JCO2012.42.6338. PMID: 23071248
-
A Translation Table for Patient-centered Comparative Effectiveness Research — Guidance to Improve the Value of Research for Clinical and Health Policy Decision Making (January 2012)
Posted January 1, 2012 by Donna Messner, PhD ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Messner DA, Mohr PE, Gliklich RE, and Dubois RW. J Comp Eff Res. 2012;1(3), 259-262. doi: 10.2217/cer.12.22.
-
Redesigning Radiotherapy Quality Assurance: Opportunities to Develop an Efficient, Evidence-based System to Support Clinical Trials-Report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. (January 2012)
Posted January 1, 2012 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Bekelman JE, Deye JA, Vikram B, Tunis SR, et al. Int J Radiat Oncol Biol Phys. 2012;83(3):782-790. doi: 10.1016/j.ijrobp.2011.12.080. PMID: 22425219. PMCID: PMC3361528
-
Adaptive Licensing & CED Workshop (November 2011)
Posted November 1, 2011 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Summary of workshop held November 2011 to explore the barriers and potential solutions of aligning adaptive licensing with coverage with evidence development (CED).
-
Improving the Quality and Efficiency of the Medicare Program Through Coverage Policy (August 2011)
Posted August 1, 2011 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
This issue brief focuses on the role of payers in achieving Medicare's "triple aim" of improving the care experience, improving health, and reducing costs. It is a collaborative effort from CMTP and the Urban Institute.
-
Improving the Quality and Efficiency of the Medicare Program Through Coverage Policy: Timely Analysis of Immediate Health Policy Issues (August 2011)
Posted August 1, 2011 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Berenson RA, Phurrough SE, Mohr PE. Urban Institute 2011: http://www.urban.org/url.cfm?ID=412392
-
A Policy Approach to the Development of Molecular Diagnostic Tests (November 2010)
Posted November 1, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Schulman KA, Tunis SR. Nat Biotechnol. 2010;28(11):1157-1159. doi: 10.1038/nbt1110-1157. PMID: 21057480
-
Why Observational Studies Should Be Among the Tools Used in Comparative Effectiveness Research (October 2010)
Posted October 10, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Dreyer NA, Tunis SR, Berger M et al. Health Aff. 2010;29(10): 1818-1825. doi: 10.1377/hlthaff.2010.0666. PMID: 20921481
-
How Best to Engage Patients, Doctors, and Other Stakeholders in Designing Comparative Effectiveness Studies (October 2010)
Posted October 1, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Hoffman A, Montgomery R, Aubry WM, Tunis SR. Health Aff(Millwood). 2010; 29(10):1834-1841. doi: 10.1377/hlthaff.2010.0675. PMID: 20921483
-
US Moves to Improve Health Decisions (August 2010)
Posted August 28, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Pearson SD. BMJ. 2010;341:c3615. doi: 10.1136/bmj.c3615. PMID: 20732966
-
MEDPAC Report (May 2010)
Posted May 1, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
A review of the comparative effectiveness research (CER) landscape in the United States and its relevance to the Medicare program. CMTP was commissioned to complete this project by the Medicare Payment Advisory Commission (MEDPAC) as part of its continuing effort to explore ways to give Medicare flexibility to be a more innovative, value-based purchaser.
-
A Pragmatic Explanatory Continuum Indicator Summary (PRECIS) Was Useful for Refining a Randomized Trial Design: Experiences from an Investigative Team (March 2010)
Posted March 1, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
D.L. Riddle et al. / Journal of Clinical Epidemiology 63 (2010) 1271e1275
-
Medicare and Medical Technology—the Growing Demand for Relevant Outcomes (Feb 2010)
Posted February 5, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Neumann PJ, Tunis SR. N Engl J Med. 2010;362(5):377-379. doi: 10.1056/NEJMp0912062. PMID: 20089955
-
Response to Comments on “Comparative Effectiveness Research (January 2010)
Posted January 1, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Benner J, McClellan M. Stat Med. 2010;29(19):1996-1997. doi: 10.1002/sim.4019. PMID: 20564311
-
Generating Evidence for CER Using Pragmatic Randomized Clinical Trials (January 2010)
Posted January 1, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Mullins CD, Whicher DM, Reese ES, Tunis SR. Pharmacoeconomics. 2012; 28(10):969-976. doi: 10.2165/11536160. PMID: 20831305
-
Uncertainty in assessing value of oncology treatments
Posted January 1, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Mullins CD, Montgomery R, Tunis SR. Oncologist. 2010; 15(s1):58-64. doi: 10.1634/theoncologist.2010-S1-58. PMID: 20237219
-
Access with Evidence Development: The US Experience (January 2010)
Posted January 1, 2010 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Mohr PE, Tunis SR. Pharmacoeconomics. 2010:28(2):153-162. doi: 10.2165/11531050. PMID: 20085391
-
Evidence Making: Developing Tools and Strategies for Comparative Effectiveness (November 2009)
Posted November 6, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Seidenfeld J. Asian Hospital & Healthcare Management. 2009;19:11-16
-
Comparative Effectiveness Research: Policy Context, Methods Development and Research Infrastructure (October 2009)
Posted October 14, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Benner J, McClellan M. Stat Med. 2010;29(19):1963-1976. doi: 10.1002/sim.3818
-
Comparative Effectiveness Research: Background, Priorities, and Methods (July 2009)
Posted July 10, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Sean Tunis's presentation on July 10, 2009, served as an informative introduction to comparative effectiveness research.
-
Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: the Need for Transformational Change (June 2009)
Posted June 30, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis SR, Whicher DM, Schwartz JS. Ann Intern Med. 2009;151(3):206-209. PMID: 1957619
-
Coverage with Evidence Development: A Case Study (June 2009)
Posted June 23, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Sean Tunis gave a presentation in June 2009 at the Health Technology Assessment International (HTAi) annual conference in Singapore.
-
Does Comparative Effectiveness Research Threaten Personalized Medicine? (May 2009)
Posted May 7, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Garber AM, Tunis SR. N Engl J Med. 2009;360(19):1925-1927. doi: 10.1056/NEJMp0901355. PMID: 19420360
-
The National Oncologic PET Registry: Lessons Learned for Coverage with Evidence Development (May 2009)
Posted May 1, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Whicher DM. J Am Coll Radiol. 2009;6(5):360-365. doi: 10.1016/j.acr.2009.10.016. PMID: 19394577
-
PRECIS: The Pragmatic Explanatory Continuum Indicator Summary (April 2009)
Posted April 1, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis SR, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers. CMAJ. 2009;180(10):E47-57. doi: 10.1503/cmaj.090523. PMID: 19372436
-
Comparative Effectiveness Research Priorities: Identifying Critical Gaps in Evidence for Clinical and Health Policy Decision Making (January 2009)
Posted January 1, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Chalkidou K, Whicher DM, Kary W, Tunis SR. Int J Technol Assess Health Care. 2009;25(3):241-248. doi: 10.107-S0266462309990225. PMID: 1961934
-
Comparative Effectiveness Research and Evidence-Based Health Policy: Experience from Four Countries (January 2009)
Posted January 1, 2009 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Chalkidou K, Tunis SR, Lopert R, et al. Milbank Q. 2009;87(2):339-367. doi: 10.1111/j.1468-0009.2006.00560.x. PMID: 19523121
-
Improving the Reporting of Pragmatic Trials: An Extension of the CONSORT Statement (Dec 2008)
Posted December 20, 2008 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis SR. BMJ. 2008;337:a2390. doi: 10.1136/bmj.a2390. PMID: 19001484. PMCID: PMC3266844
-
Engaging Decision Makers in Comparative Effectiveness Research (June 2008)
Posted June 11, 2008 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Sean Tunis gave a presentation at the US Cochrane Center Conference on Priority Setting for Systematic Reviews on July 11, 2008.
-
Challenges in Australian Policy Processes for Disinvestment from Existing, Ineffective Health Care Practices. (October 2007)
Posted October 31, 2007 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Elshaug AG, Hiller JE, Tunis SR, Moss JR. Aust New Zealand Health Policy. 2007;4:23. doi: 10.1186/17438462-4-23. PMCID: PMC2174492
-
Reflections on Science, Judgment, and Value in Evidence-Based Decision Making: A Conversation with David Eddy. (June 2007)
Posted June 19, 2007 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR. Health Aff. 2007;26(4):w500-w515. doi: 10.1977/hlthaff.26.4.w500. PMID: 17580317
-
Federal Initiatives to Support Rapid Learning About New Technologies (January 2007)
Posted January 26, 2007 by Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
Tunis SR, Carino TV, Williams RD 2nd, Bach PB. Health Aff (Millwood). 2007;26(2):w140-149. doi: 10.1377/hlthaff.26.2.w140. PMID: 17259196